Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia

We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a...

Descripción completa

Detalles Bibliográficos
Autores principales: Blatt, Stephen P., Yultyev, Aleksandr, Huang, Miao, Friedstrom, Scott, Steinbrunner, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132653/
https://www.ncbi.nlm.nih.gov/pubmed/28865937
http://dx.doi.org/10.1016/j.ajic.2017.07.019
_version_ 1783517477871812608
author Blatt, Stephen P.
Yultyev, Aleksandr
Huang, Miao
Friedstrom, Scott
Steinbrunner, Jennifer
author_facet Blatt, Stephen P.
Yultyev, Aleksandr
Huang, Miao
Friedstrom, Scott
Steinbrunner, Jennifer
author_sort Blatt, Stephen P.
collection PubMed
description We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a minimal impact on reducing antibiotic utilization among viral pneumonia patients.
format Online
Article
Text
id pubmed-7132653
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71326532020-04-08 Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia Blatt, Stephen P. Yultyev, Aleksandr Huang, Miao Friedstrom, Scott Steinbrunner, Jennifer Am J Infect Control Article We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a minimal impact on reducing antibiotic utilization among viral pneumonia patients. Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2017-12-01 2017-08-31 /pmc/articles/PMC7132653/ /pubmed/28865937 http://dx.doi.org/10.1016/j.ajic.2017.07.019 Text en © 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Blatt, Stephen P.
Yultyev, Aleksandr
Huang, Miao
Friedstrom, Scott
Steinbrunner, Jennifer
Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia
title Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia
title_full Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia
title_fullStr Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia
title_full_unstemmed Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia
title_short Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia
title_sort impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132653/
https://www.ncbi.nlm.nih.gov/pubmed/28865937
http://dx.doi.org/10.1016/j.ajic.2017.07.019
work_keys_str_mv AT blattstephenp impactofrespiratoryvirusmoleculartestingonantibioticutilizationincommunityacquiredpneumonia
AT yultyevaleksandr impactofrespiratoryvirusmoleculartestingonantibioticutilizationincommunityacquiredpneumonia
AT huangmiao impactofrespiratoryvirusmoleculartestingonantibioticutilizationincommunityacquiredpneumonia
AT friedstromscott impactofrespiratoryvirusmoleculartestingonantibioticutilizationincommunityacquiredpneumonia
AT steinbrunnerjennifer impactofrespiratoryvirusmoleculartestingonantibioticutilizationincommunityacquiredpneumonia

Ejemplares similares